发明名称 MUMBAISTATIN, A PROCESS FOR ITS PRODUCTION AND ITS USE AS A PHARMACEUTICAL
摘要 The present invention relates to a compound named Mumbaistatin which is obtainable by cultivation of the microorganism HIL-008003 (DSM 11641), and t o its pharmaceutically acceptable salts and derivatives. Mumbaistatin is a glucose-6-phosphate translocase inhibitor and can be used in the treatment o f diabetes mellitus. The present invention further relates to a process for th e production of Mumbaistatin, to the microorganism HIL-008003 (DSM 11641), to the use of Mumbaistatin and its pharmaceutically acceptable salts and derivatives as pharmaceuticals, in particular to their use in the treatment of diabetes mellitus, and to pharmaceutical compositions comprising Mumbaistati n or a pharmaceutically acceptable salt or derivative thereof.
申请公布号 CA2336135(A1) 申请公布日期 1999.12.29
申请号 CA19992336135 申请日期 1999.06.15
申请人 AVENTIS PHARMA DEUTSCHLAND GMBH 发明人 KURZ, MICHAEL;KOTA, SRIDEVI;RAMAN, MYTHILI;TARE, SWATI DHANANJAY;SCHUMMER, DIETMAR;DESHMUKH, SUNIL KUMAR;KOGLER, HERBERT;KUSHWAHA, MANOJ MANIRAM SINGH;KUMAR, ERRA KOTESWARA SATYA VIJAYA;RAMAKRISHNA, NIROGI VENKATA SATYA;SWAMY, KESHAVAPURA HOSAMANE SREEDHARA
分类号 C12N9/99;A61K31/00;A61K35/74;A61P3/10;A61P43/00;C07G99/00;C12N1/14;C12N1/20;C12P1/04;C12P1/06;C12P7/02;C12P7/24;C12P7/66;C12R1/465;(IPC1-7):C12P1/04;C07G17/00 主分类号 C12N9/99
代理机构 代理人
主权项
地址